Add BrightSurf on Google Email

Mirimus Inc.


Elite technology for gene silencing

Researchers at Mirimus Inc. developed a new technology to enhance RNA interference efficiency and accuracy, enabling functional gene annotation in normal homeostasis and disease. The new approach uses an optimized microRNA backbone to increase the success rate of RNAi screens and models.

SourceMirimus Inc.·JournalCell Reports·DateDec 16, 2013